These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4723777)

  • 21. Phosphoglycerate kinase of Bacillus stearothermophilus.
    Suzuki K; Imahori K
    J Biochem; 1974 Oct; 76(4):771-82. PubMed ID: 4436288
    [No Abstract]   [Full Text] [Related]  

  • 22. Properties and specificity of ribonuclease IIA from Thiobacillus thioparus.
    Ostrowski W; Walczak Z; Stasiuk L; Laskowski M
    Acta Biochim Pol; 1970; 17(2):73-87. PubMed ID: 5530501
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression, purification, and characterization of recombinant human factor X.
    Rudolph AE; Mullane MP; Porche-Sorbet R; Miletich JP
    Protein Expr Purif; 1997 Aug; 10(3):373-8. PubMed ID: 9268685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.
    Fearon DT; Austen KF; Ruddy S
    J Immunol; 1973 Dec; 111(6):1730-6. PubMed ID: 4796101
    [No Abstract]   [Full Text] [Related]  

  • 25. A STUDY OF THE COAGULANT ACTION OF EIGHT SNAKE VENOMS.
    NAHAS L; MACFARLANE RG; DENSON KW
    Thromb Diath Haemorrh; 1964 Dec; 12():355-67. PubMed ID: 14254694
    [No Abstract]   [Full Text] [Related]  

  • 26. The human prothrombin-activating enzyme.
    Deggeller K; Vreeken J
    Thromb Diath Haemorrh; 1969 Aug; 22(1):45-67. PubMed ID: 5821247
    [No Abstract]   [Full Text] [Related]  

  • 27. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
    Mertens K; Bertina RM
    Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of modified bovine factor VIII with enhanced biological activity using insoluble-trypsin columns.
    Vogel CN; Parfitt HE; Kingdon HS; Lundblad RL
    Thromb Diath Haemorrh; 1973 Nov; 30(2):229-34. PubMed ID: 4773363
    [No Abstract]   [Full Text] [Related]  

  • 29. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of the coagulation factors VII and X from human serum. Some properties of factor VII.
    Gladhaug A; Prydz H
    Biochim Biophys Acta; 1970 Jul; 215(1):105-11. PubMed ID: 5494503
    [No Abstract]   [Full Text] [Related]  

  • 31. [Polyadenylate synthetase from mouse ascites cells. I. Purification and characterization of the enzyme].
    Giron ML; Huppert J
    Biochim Biophys Acta; 1972 Dec; 287(3):438-47. PubMed ID: 4641253
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of factor X: kinetic properties of the reaction.
    Kosow DP; Furie B; Forastieri H
    Thromb Res; 1974 Feb; 4(2):219-27. PubMed ID: 4857482
    [No Abstract]   [Full Text] [Related]  

  • 33. The significance of crystal structure and charge of clotting-factor adsorbents.
    Howell RM; Deacon SL; Dupe RJ
    Biochem Soc Trans; 1975; 3(2):270-2. PubMed ID: 236947
    [No Abstract]   [Full Text] [Related]  

  • 34. Purification and activation of human factor X: cooperative effect of Ca++ on the activation reaction.
    Kosow DP
    Thromb Res; 1976 Dec; 9(6):565-73. PubMed ID: 1006625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular change of the factor X in blood coagulation].
    Heller A; Rasche H; Hiemeyer V
    Klin Wochenschr; 1970 Jan; 48(2):125-6. PubMed ID: 5535384
    [No Abstract]   [Full Text] [Related]  

  • 36. Properties and radioimmunoassay of canine factor X.
    Arai H; Takeda Y
    Thromb Res; 1977 Jul; 11(1):57-66. PubMed ID: 888119
    [No Abstract]   [Full Text] [Related]  

  • 37. The interaction of clotting factor X with adsorbents containing bivalent cations.
    Howell RM; Deacon SL
    Biochem Soc Trans; 1976; 4(4):718-20. PubMed ID: 12051
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of coagulation factor X by insoluble trypsin.
    Howell RM; Dupe RJ
    Biochem J; 1971 Jun; 123(2):11P-12P. PubMed ID: 5166684
    [No Abstract]   [Full Text] [Related]  

  • 39. The purification and properties of factor X from pig serum and its role in hypercoagulability in vivo.
    Dupe RJ; Howell RM
    Biochem J; 1973 Jun; 133(2):311-21. PubMed ID: 4723777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The purification and properties of activated factor X. Bovine factor X activated with Russell's viper venom.
    Radcliffe RD; Barton PG
    J Biol Chem; 1972 Dec; 247(23):7735-42. PubMed ID: 4636332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.